🇺🇸 FDA
Patent

US 6573244

Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins

expired A61KA61K38/00A61P

Quick answer

US patent 6573244 (Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins) held by The United States of America as represented by the Secretary of the Army expires Mon May 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Jun 03 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K38/00, A61P, A61P31/04, A61P39/02